Aminoacyl-tRNA synthetase defects in neurological diseases

Area of Science:

• Biochemistry
• Genetics
• Neuroscience

Background:

• Aminoacyl-tRNA synthetases (aaRSs) are crucial enzymes for protein synthesis.
• Genetic mutations in aaRSs are increasingly identified as causes of human diseases.
• aaRS mutations can lead to peripheral neuropathies (e.g., Charcot-Marie-Tooth disease) or central nervous system disorders.

Purpose of the Study:

• To review recent advancements in understanding diseases caused by aaRS mutations.
• To focus on the molecular basis and therapeutic strategies for neurodevelopmental disorders linked to biallelic mutations in cytoplasmic aaRSs.

Main Methods:

• Literature review of recent studies on aaRS mutations and associated diseases.
• Analysis of genetic, molecular, and clinical data from affected individuals.
• Examination of emerging therapeutic approaches.

Main Results:

• Monoallelic aaRS mutations are associated with dominant peripheral neuropathies.
• Biallelic mutations in cytoplasmic aaRSs frequently result in central nervous system impairment and neurodevelopmental disorders.
• Understanding the specific aaRS involved and mutation type is key to disease presentation.

Conclusions:

• aaRS mutations represent a significant genetic cause of diverse neurological conditions.
• Targeting cytoplasmic aaRSs offers potential therapeutic avenues for neurodevelopmental disorders.
• Further research is needed to fully elucidate disease mechanisms and develop effective treatments.